OZX · Class II — Moderate Risk (510(k) clearance required) · Microbiology · 21 CFR 866.3980
Classification
FDA Product Code
OZX
Device class
Class II — Moderate Risk (510(k) clearance required)
Regulation
21 CFR 866.3980
Review panel
MI
Medical specialty
Microbiology
Submission type
1
GMP exempt
N
Life sustaining
N
Implant
N
Third-party review
N
Definition
A qualitative in vitro diagnostic assay intended to detect Mycoplasma pneumoniae DNA extracted from human respiratory specimens. Detection of Mycoplasma pneumoniae DNA aids in the diagnosis of Mycoplasma pneumoniae respiratory infection in conjunction with other clinical and laboratory testing in patients exhibiting signs and symptoms of upper respiratory tract infection.